JP2012502090A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012502090A5 JP2012502090A5 JP2011526590A JP2011526590A JP2012502090A5 JP 2012502090 A5 JP2012502090 A5 JP 2012502090A5 JP 2011526590 A JP2011526590 A JP 2011526590A JP 2011526590 A JP2011526590 A JP 2011526590A JP 2012502090 A5 JP2012502090 A5 JP 2012502090A5
- Authority
- JP
- Japan
- Prior art keywords
- fatty acid
- capsule
- emulsion
- weight
- oil mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003921 oil Substances 0.000 claims 82
- 235000019198 oils Nutrition 0.000 claims 82
- 239000000203 mixture Substances 0.000 claims 81
- 239000002775 capsule Substances 0.000 claims 74
- 239000000194 fatty acid Substances 0.000 claims 71
- 235000014113 dietary fatty acids Nutrition 0.000 claims 68
- 229930195729 fatty acid Natural products 0.000 claims 68
- 150000004665 fatty acids Chemical class 0.000 claims 61
- 239000000839 emulsion Substances 0.000 claims 54
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims 50
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims 41
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims 41
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims 41
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims 41
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims 32
- 229940090949 docosahexaenoic acid Drugs 0.000 claims 25
- 239000004094 surface-active agent Substances 0.000 claims 25
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 21
- 229940072056 alginate Drugs 0.000 claims 18
- 229920000615 alginic acid Polymers 0.000 claims 18
- 150000004676 glycans Chemical class 0.000 claims 16
- 239000012528 membrane Substances 0.000 claims 16
- 229920001282 polysaccharide Polymers 0.000 claims 16
- 239000005017 polysaccharide Substances 0.000 claims 16
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims 14
- 235000010443 alginic acid Nutrition 0.000 claims 14
- -1 glycerol fatty acid ester Chemical class 0.000 claims 13
- 235000017788 Cydonia oblonga Nutrition 0.000 claims 10
- 210000003097 mucus Anatomy 0.000 claims 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 9
- 239000007764 o/w emulsion Substances 0.000 claims 8
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 claims 7
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 claims 7
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 claims 7
- 230000005802 health problem Effects 0.000 claims 7
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 claims 6
- 125000004494 ethyl ester group Chemical group 0.000 claims 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 6
- 235000021588 free fatty acids Nutrition 0.000 claims 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 6
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims 6
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims 6
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 6
- 229920000053 polysorbate 80 Polymers 0.000 claims 6
- 230000000813 microbial effect Effects 0.000 claims 5
- 229940012843 omega-3 fatty acid Drugs 0.000 claims 5
- 150000003626 triacylglycerols Chemical class 0.000 claims 5
- 235000015112 vegetable and seed oil Nutrition 0.000 claims 5
- 239000008158 vegetable oil Substances 0.000 claims 5
- 206010019280 Heart failures Diseases 0.000 claims 4
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims 4
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims 4
- 208000006575 hypertriglyceridemia Diseases 0.000 claims 4
- 239000004014 plasticizer Substances 0.000 claims 4
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 claims 3
- IEORSVTYLWZQJQ-UHFFFAOYSA-N 2-(2-nonylphenoxy)ethanol Chemical compound CCCCCCCCCC1=CC=CC=C1OCCO IEORSVTYLWZQJQ-UHFFFAOYSA-N 0.000 claims 3
- BHIZVZJETFVJMJ-UHFFFAOYSA-N 2-hydroxypropyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(C)O BHIZVZJETFVJMJ-UHFFFAOYSA-N 0.000 claims 3
- GHHURQMJLARIDK-UHFFFAOYSA-N 2-hydroxypropyl octanoate Chemical compound CCCCCCCC(=O)OCC(C)O GHHURQMJLARIDK-UHFFFAOYSA-N 0.000 claims 3
- 208000021866 Dressler syndrome Diseases 0.000 claims 3
- 102000004877 Insulin Human genes 0.000 claims 3
- 108090001061 Insulin Proteins 0.000 claims 3
- 239000002202 Polyethylene glycol Substances 0.000 claims 3
- 229920001213 Polysorbate 20 Polymers 0.000 claims 3
- 229920001219 Polysorbate 40 Polymers 0.000 claims 3
- 230000002159 abnormal effect Effects 0.000 claims 3
- 230000009084 cardiovascular function Effects 0.000 claims 3
- 235000015872 dietary supplement Nutrition 0.000 claims 3
- 150000002148 esters Chemical class 0.000 claims 3
- 235000021323 fish oil Nutrition 0.000 claims 3
- 230000036737 immune function Effects 0.000 claims 3
- 229940125396 insulin Drugs 0.000 claims 3
- 150000002632 lipids Chemical class 0.000 claims 3
- 150000004668 long chain fatty acids Chemical class 0.000 claims 3
- 229960003511 macrogol Drugs 0.000 claims 3
- 230000007472 neurodevelopment Effects 0.000 claims 3
- 229920000847 nonoxynol Polymers 0.000 claims 3
- 150000003904 phospholipids Chemical class 0.000 claims 3
- 239000008389 polyethoxylated castor oil Substances 0.000 claims 3
- 229920001223 polyethylene glycol Polymers 0.000 claims 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims 3
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 claims 3
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 claims 3
- 229920001451 polypropylene glycol Polymers 0.000 claims 3
- 229940068977 polysorbate 20 Drugs 0.000 claims 3
- 229940101027 polysorbate 40 Drugs 0.000 claims 3
- 229940068968 polysorbate 80 Drugs 0.000 claims 3
- 229940026235 propylene glycol monolaurate Drugs 0.000 claims 3
- 230000001105 regulatory effect Effects 0.000 claims 3
- 230000004382 visual function Effects 0.000 claims 3
- LGHXTTIAZFVCCU-SSVNFBSYSA-N (2E,4E,6E,8E)-octadeca-2,4,6,8-tetraenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C(O)=O LGHXTTIAZFVCCU-SSVNFBSYSA-N 0.000 claims 2
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 claims 2
- OQOCQFSPEWCSDO-JLNKQSITSA-N 6Z,9Z,12Z,15Z,18Z-Heneicosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCC(O)=O OQOCQFSPEWCSDO-JLNKQSITSA-N 0.000 claims 2
- 235000021294 Docosapentaenoic acid Nutrition 0.000 claims 2
- 239000000654 additive Substances 0.000 claims 2
- 230000000996 additive effect Effects 0.000 claims 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims 2
- 239000003963 antioxidant agent Substances 0.000 claims 2
- 239000003086 colorant Substances 0.000 claims 2
- IQLUYYHUNSSHIY-HZUMYPAESA-N eicosatetraenoic acid Chemical compound CCCCCCCCCCC\C=C\C=C\C=C\C=C\C(O)=O IQLUYYHUNSSHIY-HZUMYPAESA-N 0.000 claims 2
- 235000003599 food sweetener Nutrition 0.000 claims 2
- 239000003349 gelling agent Substances 0.000 claims 2
- OQOCQFSPEWCSDO-UHFFFAOYSA-N heneicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCCC(O)=O OQOCQFSPEWCSDO-UHFFFAOYSA-N 0.000 claims 2
- 229960004488 linolenic acid Drugs 0.000 claims 2
- 235000020665 omega-6 fatty acid Nutrition 0.000 claims 2
- 229940033080 omega-6 fatty acid Drugs 0.000 claims 2
- 239000004848 polyfunctional curative Substances 0.000 claims 2
- 239000003381 stabilizer Substances 0.000 claims 2
- 239000003765 sweetening agent Substances 0.000 claims 2
- TYLNXKAVUJJPMU-DNKOKRCQSA-N Docosahexaenoic acid ethyl ester Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(=O)OCC TYLNXKAVUJJPMU-DNKOKRCQSA-N 0.000 claims 1
- 229920000064 Ethyl eicosapentaenoic acid Polymers 0.000 claims 1
- 206010061216 Infarction Diseases 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 claims 1
- SSQPWTVBQMWLSZ-AAQCHOMXSA-N ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate Chemical compound CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC SSQPWTVBQMWLSZ-AAQCHOMXSA-N 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 210000004165 myocardium Anatomy 0.000 claims 1
- 239000006014 omega-3 oil Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940067631 phospholipid Drugs 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 125000005457 triglyceride group Chemical group 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/207,824 US20100062057A1 (en) | 2008-09-10 | 2008-09-10 | Formulation |
| US12/207,824 | 2008-09-10 | ||
| PCT/IB2009/006933 WO2010029433A1 (en) | 2008-09-10 | 2009-09-10 | A polysaccharide capsule enclosing a fatty acid oil-containing emulsion |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012502090A JP2012502090A (ja) | 2012-01-26 |
| JP2012502090A5 true JP2012502090A5 (enExample) | 2012-11-01 |
Family
ID=41799505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011526590A Pending JP2012502090A (ja) | 2008-09-10 | 2009-09-10 | 脂肪酸油含有乳剤を封入した多糖類カプセル |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20100062057A1 (enExample) |
| EP (1) | EP2341901A4 (enExample) |
| JP (1) | JP2012502090A (enExample) |
| KR (1) | KR20110058881A (enExample) |
| CN (1) | CN102209534A (enExample) |
| AU (1) | AU2009290542A1 (enExample) |
| BR (1) | BRPI0918429A2 (enExample) |
| CA (1) | CA2736812A1 (enExample) |
| EA (1) | EA201170433A1 (enExample) |
| MX (1) | MX2011002640A (enExample) |
| WO (1) | WO2010029433A1 (enExample) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2405903B1 (en) | 2009-03-09 | 2024-04-10 | Basf As | Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof |
| CN102596251B (zh) * | 2009-09-10 | 2014-06-11 | Fmc有限公司 | 高强度无缝海藻酸盐胶囊 |
| US9370493B2 (en) * | 2009-10-23 | 2016-06-21 | Pronova Biopharma Norge As | Coated capsules and tablets of a fatty acid oil mixture |
| AP3082A (en) | 2009-10-30 | 2015-01-31 | Tharos Ltd | Solvent-free process for obtaining phospholipids and neutral enriched krill oils |
| DE102010001179A1 (de) * | 2010-01-25 | 2011-07-28 | Technische Universität Dresden, 01069 | Verwendung von Hydrogelen auf Basis guluronsäure- und/oder mannuronsäurehaltiger Polysaccharide zur Behandlung von Beschädigungen des Nervensystems, zur Förderung des Nervenwachstums, zur Behandlung von neurodegenerativen Erkrankungen und zur Kultivierung von Neuronen |
| GB201006204D0 (en) * | 2010-04-14 | 2010-06-02 | Ayanda As | Composition |
| CA2706272C (en) | 2010-06-03 | 2020-05-05 | Accucaps Industries Limited | Multi phase soft gel capsules, apparatus and method thereof |
| CA2706270C (en) * | 2010-06-03 | 2020-01-07 | Accucaps Industries Limited | Pharmaceutical formulations of statins and omega-3 fatty acids for encapsulation |
| CN103384478B (zh) | 2010-12-29 | 2016-11-23 | 雅培制药有限公司 | 降低婴儿、幼儿或儿童的坏死性小肠结肠炎、腹痛和短肠综合征的发病率的方法 |
| ITMI20111050A1 (it) * | 2011-06-10 | 2012-12-11 | Sevecom Spa | Uso di emulsionanti in associazione con oleine vegetali in un alimento per animali. |
| RS56394B1 (sr) * | 2011-06-15 | 2017-12-29 | Stable Solutions Llc | Terapeutska primena parenteralnog kril ulja |
| US10052352B2 (en) | 2011-06-15 | 2018-08-21 | Stable Solutions Llc | Therapeutic application of parenteral krill oil |
| US8895074B2 (en) * | 2011-06-15 | 2014-11-25 | Stable Solutions Llc | Therapeutic application of parenteral krill oil |
| WO2013093630A2 (en) * | 2011-12-22 | 2013-06-27 | Pronova Biopharma Norge As | Gelatin/alginate delayed release capsules comprising omega-3 fatty acids, and methods and uses thereof |
| CN104321055A (zh) | 2012-01-06 | 2015-01-28 | 翁特拉制药公司 | 游离酸形式的ω-3多不饱和脂肪酸的富含dpa组合物 |
| WO2014074625A1 (en) | 2012-02-21 | 2014-05-15 | Allurion Technologies, Inc. | Anatomically adapted ingestible delivery systems and methods |
| CA2865056C (en) | 2012-02-21 | 2021-07-20 | Allurion Technologies, Inc. | Methods and devices for deploying and releasing a temporary implant within the body |
| US10182932B2 (en) | 2012-02-21 | 2019-01-22 | Allurion Technologies, Inc. | Methods and devices for deploying and releasing a temporary implant within the body |
| JPWO2013129168A1 (ja) * | 2012-02-29 | 2015-07-30 | 日清オイリオグループ株式会社 | カプセル食品およびカプセル含有油脂組成物 |
| US9452135B2 (en) | 2012-03-20 | 2016-09-27 | Particle Dynamics International, Llc | Gelling agent-based dosage form |
| IN2014DN08449A (enExample) | 2012-03-30 | 2015-05-08 | Sancilio & Company Inc | |
| US9480651B2 (en) | 2012-03-30 | 2016-11-01 | Sancilio & Company, Inc. | Omega-3 fatty acid ester compositions unitary pharmaceutical dosage forms |
| US10898458B2 (en) | 2012-03-30 | 2021-01-26 | Micelle Biopharma, Inc. | Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states |
| US20160228397A1 (en) | 2012-03-30 | 2016-08-11 | Sancilio & Company, Inc. | Omega-3 fatty acid ester compositions |
| US20130295173A1 (en) | 2012-05-07 | 2013-11-07 | Omthera Pharmaceuticals, Inc. | Compositions of statins and omega-3 fatty acids |
| EP2866800A4 (en) * | 2012-06-29 | 2015-12-16 | Amarin Pharmaceuticals Ie Ltd | METHOD FOR THE TREATMENT OF METABOLIC SYNDROME IN CHILDREN |
| GB201216385D0 (en) * | 2012-09-13 | 2012-10-31 | Chrysalis Pharma Ag | A pharmaceutical composition |
| WO2016012881A1 (en) | 2014-07-21 | 2016-01-28 | Sevecom S.P.A. | Powdered emulsion for animal feed |
| US20170367985A1 (en) * | 2014-12-23 | 2017-12-28 | Fmc Corporation | Enteric Film Coating Compositions, Method of Coating, and Coated Forms |
| MA41611A (fr) * | 2015-02-23 | 2018-01-02 | Omthera Pharmaceuticals Inc | Préparations en milli-capsules comprenant des acides gras polyinsaturés libres |
| US20180042851A1 (en) * | 2015-03-12 | 2018-02-15 | Fmc Corporation | Solid dispersions |
| GB201509606D0 (en) * | 2015-06-03 | 2015-07-15 | Anabio Technologies Ltd | Microencapsulates containing stabilised marine-derived oil, and methods for production thereof |
| ES2607715B1 (es) * | 2015-10-01 | 2018-01-17 | Solutex Na, Lcc | Proceso para la preparación y estabilización de emulsiones con omega-3 mediante redes cristalinas isométricas de derivados de celulosa |
| KR101634314B1 (ko) * | 2015-10-22 | 2016-06-30 | 한방약초힐링 농업회사법인주식회사 | 식물성 오메가-3 함유 기능성 미세분말 제조방법 |
| US20180325785A1 (en) * | 2015-11-25 | 2018-11-15 | Asanuma Corporation | Method for manufacturing capsule |
| EP3755240B1 (en) | 2018-02-26 | 2024-03-27 | Allurion Technologies, Inc. | Automatic-sealing balloon-filling catheter system |
| CA3091686A1 (en) | 2018-03-15 | 2019-09-19 | R.P. Scherer Technologies, Llc | Enteric softgel capsules |
| CN108704588B (zh) * | 2018-06-29 | 2020-10-09 | 广西壮族自治区林业科学研究院 | 一种微胶囊化酸性水溶液的制备方法 |
| US11098813B2 (en) | 2018-07-06 | 2021-08-24 | Allurion Technologies, Inc. | Binary fluid control valve system |
| US11497900B2 (en) | 2018-12-13 | 2022-11-15 | Allurion Technologies, Inc. | Enhanced fluid delivery system |
| US12514826B2 (en) | 2019-04-30 | 2026-01-06 | Dsm Ip Assets B.V. | Delivery system for polyunsaturated fatty acids |
| WO2021220236A1 (en) * | 2020-05-01 | 2021-11-04 | Cadila Healthcare Limited | Pharmaceutical compositions for combination therapy |
| US12246163B2 (en) | 2023-04-12 | 2025-03-11 | Allurion Technologies, Inc. | Automatic-sealing balloon-filling catheter system |
| US12245962B2 (en) | 2023-04-12 | 2025-03-11 | Allurion Technologies, Inc. | Balloon sealing and fill valve |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1015251A (en) * | 1963-03-12 | 1965-12-31 | Glaxo Lab Ltd | Aqueous pharmaceutical compositions in capsule form |
| US3682654A (en) * | 1970-03-13 | 1972-08-08 | Gen Mills Inc | Artificial flavored berries and process of preparing same |
| US4507327A (en) * | 1983-05-23 | 1985-03-26 | Q.P. Corporation | Process for preparing edible products in the form of capsules |
| JPS60100516A (ja) * | 1983-11-04 | 1985-06-04 | Takeda Chem Ind Ltd | 徐放型マイクロカプセルの製造法 |
| JPS6121070A (ja) * | 1984-07-11 | 1986-01-29 | Q P Corp | 魚卵様食品の製法 |
| GB2209937B (en) * | 1987-09-21 | 1991-07-03 | Depiopharm S A | Water insoluble polypeptides |
| ATE83686T1 (de) * | 1987-10-28 | 1993-01-15 | Solvay Umweltchemie Gmbh | Zur selektiven abtrennung von metallkationen aus waessrigen loesungen geeignetes teilchenfoermiges mittel, verfahren zu seiner herstellung und seine verwendung. |
| GB8819110D0 (en) * | 1988-08-11 | 1988-09-14 | Norsk Hydro As | Antihypertensive drug & method for production |
| KR930006431B1 (ko) * | 1990-10-11 | 1993-07-16 | 재단법인 한국화학연구소 | 약물의 미세캡슐화 방법 |
| CH683149A5 (fr) * | 1991-07-22 | 1994-01-31 | Debio Rech Pharma Sa | Procédé pour la préparation de microsphères en matériau polymère biodégradable. |
| EP0573978B1 (en) * | 1992-06-12 | 1999-04-21 | Kao Corporation | Bath additive composition comprising surfactant-containing seamless capsules and method for producing the capsules. |
| MY118354A (en) * | 1995-05-01 | 2004-10-30 | Scarista Ltd | 1,3-propane diol derivatives as bioactive compounds |
| JP3238350B2 (ja) * | 1997-05-27 | 2001-12-10 | 三粧化研株式会社 | 可食性パール状カプセルおよびその製造法 |
| EP1025842B1 (en) * | 1997-10-30 | 2004-07-21 | Morishita Jintan Co., Ltd. | Double-leyered capsule of unsaturated fatty acid or derivative thereof and process for producing the same |
| KR100587551B1 (ko) * | 1997-12-10 | 2006-06-08 | 싸이클로스포린 테라퓨틱스 리미티드 | 오메가-3 지방산 오일을 함유하는 약학 조성물 |
| US6214376B1 (en) * | 1998-08-25 | 2001-04-10 | Banner Pharmacaps, Inc. | Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture |
| ATE313375T1 (de) * | 2000-03-04 | 2006-01-15 | Cognis Ip Man Gmbh | Mikrokapseln |
| US7264824B1 (en) * | 2000-04-13 | 2007-09-04 | Meduna Arzneimittel Gmbh | Oral dosage form |
| DE60022987T2 (de) * | 2000-05-22 | 2006-10-19 | Pro Aparts - Investimentos E Consultoria Lda., Funchal | Fettsäurezusammensetzung, die wenigstens 80 Gew.-% EPA und DHA enthält |
| AR039170A1 (es) * | 2002-03-28 | 2005-02-09 | Bio Dar Ltd | Co-granulos de dha y romero y metodos de uso |
| NO20021592D0 (no) * | 2002-04-04 | 2002-04-04 | Fmc Biopolymer As | Polysakkaridkapsler og fremgangsmåte ved fremstilling derav |
| US6974592B2 (en) * | 2002-04-11 | 2005-12-13 | Ocean Nutrition Canada Limited | Encapsulated agglomeration of microcapsules and method for the preparation thereof |
| EP1535595A4 (en) * | 2002-06-24 | 2011-03-23 | Chugai Pharmaceutical Co Ltd | METHOD FOR PRODUCING AN ASPHARIC SEAMLESS CAPSULE AND DEVICE THEREFOR |
| US7431986B2 (en) * | 2002-07-24 | 2008-10-07 | General Mills, Inc. | Encapsulation of sensitive components using pre-emulsification |
| AU2003301121A1 (en) * | 2002-12-18 | 2004-07-14 | Pain Therapeutics, Inc. | Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats |
| US20040254357A1 (en) * | 2002-12-19 | 2004-12-16 | Zaloga Gary P. | Fatty acid phenolic conjugates |
| ITMI20031617A1 (it) * | 2003-08-06 | 2005-02-07 | Fond Carlo E Dirce Callerio Onlus | Microcapsule a doppio strato di polisaccaridi utilizzabili |
-
2008
- 2008-09-10 US US12/207,824 patent/US20100062057A1/en not_active Abandoned
-
2009
- 2009-09-10 KR KR1020117008242A patent/KR20110058881A/ko not_active Ceased
- 2009-09-10 EP EP09812757.4A patent/EP2341901A4/en not_active Withdrawn
- 2009-09-10 JP JP2011526590A patent/JP2012502090A/ja active Pending
- 2009-09-10 EA EA201170433A patent/EA201170433A1/ru unknown
- 2009-09-10 CN CN2009801446021A patent/CN102209534A/zh active Pending
- 2009-09-10 MX MX2011002640A patent/MX2011002640A/es not_active Application Discontinuation
- 2009-09-10 US US13/062,997 patent/US20110262534A1/en not_active Abandoned
- 2009-09-10 BR BRPI0918429A patent/BRPI0918429A2/pt not_active IP Right Cessation
- 2009-09-10 CA CA2736812A patent/CA2736812A1/en not_active Abandoned
- 2009-09-10 WO PCT/IB2009/006933 patent/WO2010029433A1/en not_active Ceased
- 2009-09-10 AU AU2009290542A patent/AU2009290542A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012502090A5 (enExample) | ||
| EP3763364B1 (en) | Self-emulsifying composition of omega-3 fatty acid | |
| US20110262534A1 (en) | polysaccharide capsule enclosing a fatty acid oil-containing emulsion | |
| JP6723009B2 (ja) | 脂肪酸油混合物及び界面活性剤を含む組成物、並びにその方法及び使用 | |
| JP2012519728A5 (enExample) | ||
| JP2022121571A (ja) | ω３脂肪酸の自己乳化組成物 | |
| EP3062785B1 (en) | Enteric soft capsules comprising polyunsaturated fatty acids | |
| US20040209953A1 (en) | Glyceride compositions and methods of making and using same | |
| JP2015520235A5 (enExample) | ||
| KR20210083395A (ko) | 지방산 오일 혼합물의 코팅된 캡슐 및 정제 | |
| JP2021137035A5 (ja) | 高度不飽和脂肪酸のトリグリセリドを含む組成物 | |
| US9044043B2 (en) | Balanced fat composition and use thereof in a liquid nutritional composition suitable for enteral feeding | |
| JP2011519349A5 (enExample) | ||
| JPWO2005061684A1 (ja) | 油脂組成物 | |
| JP2013538817A5 (enExample) | ||
| JP2016501248A5 (enExample) | ||
| WO2013072767A1 (en) | Compositions and preconcentrates comprising at least one salicylate and omega-3 fatty acid oil mixture | |
| WO2014095628A1 (en) | Oral formulation containing a statin in omega-3 polyunsaturated fatty acids (n-3 pufa) | |
| WO2021156385A1 (en) | Lipid composition comprising omega-3 fatty acids | |
| JPWO2009031275A1 (ja) | 抗酸化剤 | |
| WO2011128626A1 (en) | Essential fatty acid gelled composition | |
| JP2017516820A5 (enExample) | ||
| RU2017145265A (ru) | Фармацевтические композиции, содержащие epa и сердечно-сосудистое средство, и способы их применения | |
| JP2021084895A (ja) | ω３脂肪酸の自己乳化製剤 | |
| JP2011207809A (ja) | ソフトカプセル用の充填組成物 |